Migrainous infarction: Aspects on risk factors and therapy

Current Pain and Headache Reports

Volumn 16, Issue 3, 2012, Pages 255-260

  Laurell, Katarina ^a   Lundström, Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebrovascular disorder; Complicated migraine; Ischemic stroke; Migraine; Migraine with aura; Migrainous infarction; Risk factors

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; FUROSEMIDE; KETAMINE; LAMOTRIGINE; MAGNESIUM; NIFEDIPINE; NITRATE; ORAL CONTRACEPTIVE AGENT; PROCHLORPERAZINE; TRIPTAN DERIVATIVE; VALPROIC ACID;

ARTERY DISSECTION; BRAIN ATHEROSCLEROSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CIGARETTE SMOKING; CLINICAL FEATURE; COHORT ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE TITRATION; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; MIGRAINE AURA; MIGRAINOUS INFARCTION; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION; SYMPTOM;

CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIGRAINE WITH AURA; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SMOKING; SOCIAL CLASS; STROKE;

EID: 84861092573     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-012-0262-2     Document Type: Review

References (60)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
2. WHO. Global burden of stroke. 2011.
3. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355-69.
4. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915-26.
5. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and metaanalysis of observational studies. BMJ. 2005;330:63.
6. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and metaanalysis. BMJ. 2009;339:b3914.
7. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated metaanalysis. Am J Med. 2010;123:612-24.
8. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI Camera Study. Brain. 2005;128:2068-77. (Pubitemid 41253274)
9. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO Collaborative Study. Bull World Health Organ. 1980;58:113-30. (Pubitemid 10013261)
10. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Tatlisumak T. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke. 2009;40:1195-203.
11. Varona JF, Guerra JM, Bermejo F, Molina JA, Gomez de la Camara A. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term. Eur Neurol. 2007;57:212-8. (Pubitemid 46701478)
12. Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin. 1992;10:113-24.
13. Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, Olsson T. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in Northern Sweden. Stroke. 1997;28:1702-9. (Pubitemid 27391436)
14. Kittner SJ, Stern BJ, Wozniak M, Buchholz DW, Earley CJ, Feeser BR, Johnson CJ, Macko RF, McCarter RJ, Price TR, Sherwin R, Sloan MA, Wityk RJ. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;50:890-4. (Pubitemid 28212811)
15. Adams Jr HP, Kappelle LJ, Biller J, Gordon DL, Love BB, Gomez F, Heffner M. Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of Stroke in young adults. Arch Neurol. 1995;52:491-5.
16. Rasura M, Spalloni A, Ferrari M, De Castro S, Patella R, Lisi F, Beccia M. A case series of young stroke in Rome. Eur J Neurol. 2006;13:146-52.
17. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-57. (Pubitemid 32777747)
18. Oral contraceptives and stroke in young women. Associated risk factors. JAMA. 1975;231:718-722.
19. Henrich JB, Horwitz RI. A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol. 1989;42:773-80. (Pubitemid 19213124)
20. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d'Anglejan-Chatillon J, Bousser MG. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ. 1995;310:830-3.
21. MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, Kittner SJ. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in Young Women Study. Stroke. 2007;38:2438-45. (Pubitemid 47329619)
22. Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, Kuntz RE, Cook EF, Mauri L. Lack of association between migraine headache and patent foramen ovale: results of a case- control study. Circulation. 2010;121:1406-12.
23. Woods TD, Harmann L, Purath T, Ramamurthy S, Subramanian S, Jackson S, Tarima S. Small- and moderate-size right-to-left shunts identified by saline contrast echocardiography are normal and unrelated to migraine headache. Chest. 2010;138:264-9.
24. Feurer R, Sadikovic S, Sepp D, Esposito L, Schleef M, Bockelbrink A, Schwarze J, Hemmer B, Sander D, Poppert H. Patent foramen ovale is not associated with an increased risk of stroke recurrence. Eur J Neurol. 2010;17:1339-45.
25. Thaler DE, Saver JL. Cryptogenic stroke and patent foramen ovale. Curr Opin Cardiol. 2008;23:537-44.
26. Tzourio C, Benslamia L, Guillon B, Aidi S, Bertrand M, Berthet K, Bousser MG. Migraine and the risk of cervical artery dissection: a case-control study. Neurology. 2002;59:435-7. (Pubitemid 34857939)
27. The international classification of headache disorders: 2nd edition. Cephalalgia Int J Headache. 2004;24(Suppl 1):9-160.
28. Rothrock JF, Walicke P, Swenson MR, Lyden PD, Logan WR. Migrainous stroke. Arch Neurol. 1988;45:63-7. (Pubitemid 18018589)
29. Bogousslavsky J, Regli F, Van Melle G, Payot M, Uske A. Migraine stroke. Neurology. 1988;38:223-7. (Pubitemid 18036841)
30. Broderick JP, Swanson JW. Migraine-related strokes. Clinical profile and prognosis in 20 patients. Arch Neurol. 1987;44:868-71.
31. Sochurkova D, Moreau T, Lemesle M, Menassa M, Giroud M, Dumas R. Migraine history and migraine-induced stroke in the Dijon Stroke Registry. Neuroepidemiology. 1999;18:85-91. (Pubitemid 29095756)
32. Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Balcells M, Targa C. Migrainous cerebral infarction in the sagrat cor hospital of Barcelona Stroke Registry. Cephalalgia Int J Headache. 2003;23:389-94. (Pubitemid 36688130)
33. Laurell K, Artto V, Bendtsen L, Hagen K, Kallela M, Meyer EL, Putaala J, Tronvik E, Zwart JA, Linde M. Migrainous infarction: a Nordic Multicenter Study. Eur J Neurol. 2011;18:1220-6.
34. Marshall N, Maclaurin WA, Koulouris G. MRA captures vasospasm in fatal migrainous infarction. Headache. 2007;47:280-3.
35. Wolf ME, Szabo K, Griebe M, Forster A, Gass A, Hennerici MG, Kern R. Clinical and MRI characteristics of acute migrainous infarction. Neurology. 2011;76:1911-7.
36. Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol. 1983;13:633-41. (Pubitemid 13103461)
37. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann Neurol. 1981;9:344-52. (Pubitemid 11106551)
38. Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31:17-35.
39. Pezzini A, Del Zotto E, Giossi A, Volonghi I, Grassi M, Padovani A. The migraine-ischemic stroke connection: potential pathogenic mechanisms. Curr Mol Med. 2009;9:215-26.
40. Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol. 2012;11:92-100.
41. Bates D, Ashford E, Dawson R, Ensink FB, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P. Subcutaneous sumatriptan during themigraine aura. Sumatriptan Aura Study Group. Neurology. 1994;44:1587-92.
42. Cavazos JE, Caress JB, Chilukuri VR, Devlin T, Gray L, Hurwitz BJ. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet. 1994;343:1105-6. (Pubitemid 24128229)
43. Jayamaha JE, Street MK. Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med. 1995;21:82-3.
44. Vijayan N, Peacock JH. Spinal cord infarction during use of zolmitriptan: a case report. Headache. 2000;40:57-60. (Pubitemid 30091522)
45. Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache. 2004;44:642-51. (Pubitemid 38931894)
46. Skoloudik D, Kral M, Sanak D, Vlachova I, Hlustik P, Michalkova K, Herzig R, Kanovsky P. Thrombolytic treatment of ischaemic stroke occurring during a migrainous attack: a case report. Cephalalgia Int J Headache. 2010;30:368-72.
47. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ecass, Atlantis, ninds, and epithet trials. Lancet. 2010;375:1695-703.
48. Chernyshev OY, Martin-Schild S, Albright KC, Barreto A, Misra V, Acosta I, Grotta JC, Savitz SI. Safety of TPA in stroke mimics and neuroimaging- negative cerebral ischemia. Neurology. 2010;74:1340-5.
49. Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified national institutes of health stroke scale for use in stroke clinical trials: prospective reliability and validity. Stroke. 2002;33:1261-6. (Pubitemid 34517045)
50. Winkler DT, Fluri F, Fuhr P, Wetzel SG, Lyrer PA, Ruegg S, Engelter ST. Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke. 2009;40:1522-5.
51. Uchino K, Massaro L, Hammer MD. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy? Cerebrovasc Dis. 2010;29:57-61.
52. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009;8:261-9.
53. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Sohngen M, Teal PA,Wilhelm-Ogunbiyi K, Wintermark M, Warach S. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion ct (dias-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009;8:141-50.
54. Hachinski V, Norris JW, Edmeads J, Cooper PW. Ergotamine and cerebral blood flow. Stroke. 1978;9:594-6. (Pubitemid 9018886)
55. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS. EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol. 2006;13:560-72. (Pubitemid 43873628)
56. D'Andrea G, Colavito D, Dalle Carbonare M, Leon A. Migraine with aura: conventional and non-conventional treatments. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2011;32 Suppl 1:S121-9.
57. Goldner JA, Levitt LP. Treatment of complicated migraine with sublingual nifedipine. Headache. 1987;27:484-6. (Pubitemid 18092037)
58. Lampl C, Katsarava Z, Diener HC, Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:1730-2. (Pubitemid 41697646)
59. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
60. Rothrock J, North J, Madden K, Lyden P, Fleck P, Dittrich H. Migraine and migrainous stroke: risk factors and prognosis. Neurology. 1993;43:2473-6. (Pubitemid 24004530)